Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Read the full story at source →
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Read the full story at source →
Post Comment